Literature DB >> 773587

Amitriptyline plasma levels and therapeutic response.

V E Ziegler, B T Co, J R Taylor, P J Clayton, J T Biggs.   

Abstract

Eighteen depressed outpatients were treated for 6 wk with amitriptyline. Clinical improvement was monitored using the Hamilton Depression Rating Scale administered by two psychiatrists blind to the tricyclic used for treatment, dosage, and plasma levels. Amitriptyline and its desmethyl metabolite, notriptyline, were assayed twice weekly by gas chromatography-mass fragmentography. For the 17 patients having total tricyclic plasma levels between 0 and 250 ng/ml, there was a negative correlation between the Hamilton score and the mean total tricyclic level (p less than 0.01) and amitriptyline level (p less than 0.005). The mean nortriptyline level did not significantly correlate with the Hamilton score. The 10 patients having mean total tricyclic levels above 95 ng/ml had lower median Hamilton scores at week 3 (p less than 0.025) and at week 6 (p less than 0.0025) than those whose tricyclics were lower. The percentage of recovered patients increases significantly as the plasma levels rise to 250 ng/ml, the maximum plasma level considered in this study.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 773587     DOI: 10.1002/cpt1976196795

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  26 in total

1.  Clinical response and plasma concentration of amitriptyline and its metabolite nortriptyline.

Authors:  S Vandel; B Vandel; M Sandoz; G Allers; P Bechtel; R Volmat
Journal:  Eur J Clin Pharmacol       Date:  1978-11-27       Impact factor: 2.953

Review 2.  Plasma level monitoring of tricyclic antidepressant therapy.

Authors:  L F Gram
Journal:  Clin Pharmacokinet       Date:  1977 Jul-Aug       Impact factor: 6.447

3.  Imipramine: clinical effects and pharmacokinetic variability.

Authors:  N Reisby; L F Gram; P Bech; A Nagy; G O Petersen; J Ortmann; I Ibsen; S J Dencker; O Jacobsen; O Krautwald; I Sondergaard; J Christiansen
Journal:  Psychopharmacology (Berl)       Date:  1977-11-15       Impact factor: 4.530

Review 4.  The relationship between antidepressant response and tricyclic antidepressant plasma concentrations. A retrospective analysis of the literature using logistic regression analysis.

Authors:  P J Perry; B M Pfohl; S G Holstad
Journal:  Clin Pharmacokinet       Date:  1987-12       Impact factor: 6.447

Review 5.  Pharmacokinetic optimisation of tricyclic antidepressant therapy.

Authors:  M Furlanut; P Benetello; E Spina
Journal:  Clin Pharmacokinet       Date:  1993-04       Impact factor: 6.447

6.  The interaction of trazodone with rat brain muscarinic cholinoceptors.

Authors:  D K Hyslop; D P Taylor
Journal:  Br J Pharmacol       Date:  1980       Impact factor: 8.739

Review 7.  Current antidepressant drugs: their clinical use.

Authors:  L E Hollister
Journal:  Drugs       Date:  1981-08       Impact factor: 9.546

8.  Relationship between the plasma concentration of clomipramine and desmethylclomipramine in depressive patients and the clinical response.

Authors:  B Vandel; S Vandel; J M Jounet; G Allers; R Volmat
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

9.  Specific radioimmunoassay of amitriptyline and nortriptyline.

Authors:  D J Brunswick; B Needelman; J Mendels
Journal:  Br J Clin Pharmacol       Date:  1979-04       Impact factor: 4.335

10.  Sex differences in response to oral amitriptyline in three animal models of depression in C57BL/6J mice.

Authors:  B J Caldarone; K Karthigeyan; A Harrist; J G Hunsberger; E Wittmack; S L King; P Jatlow; M R Picciotto
Journal:  Psychopharmacology (Berl)       Date:  2003-07-15       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.